Wealthtrust Fairport buys $8,451,293 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Wealthtrust Fairport scooped up 1,855 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 3, 2016. The investment management firm now holds a total of 75,994 shares of Stryker Corporation which is valued at $8,451,293.Stryker Corporation makes up approximately 1.14% of Wealthtrust Fairport’s portfolio.

Other Hedge Funds, Including , Harfst Associates reduced its stake in SYK by selling 20,690 shares or 90.95% in the most recent quarter. The Hedge Fund company now holds 2,060 shares of SYK which is valued at $229,093. Stryker Corporation makes up approx 0.14% of Harfst Associates’s portfolio.Tci Wealth Advisors reduced its stake in SYK by selling 20 shares or 3.06% in the most recent quarter. The Hedge Fund company now holds 633 shares of SYK which is valued at $69,003. Stryker Corporation makes up approx 0.04% of Tci Wealth Advisors’s portfolio.Kames Capital Plc reduced its stake in SYK by selling 1,490 shares or 8.14% in the most recent quarter. The Hedge Fund company now holds 16,809 shares of SYK which is valued at $1,832,349. Stryker Corporation makes up approx 0.06% of Kames Capital Plc’s portfolio. Atwood Palmer Inc sold out all of its stake in SYK during the most recent quarter. The investment firm sold 50 shares of SYK which is valued $5,451.Van Cleef Asset Managementinc boosted its stake in SYK in the latest quarter, The investment management firm added 1,350 additional shares and now holds a total of 39,603 shares of Stryker Corporation which is valued at $4,332,568. Stryker Corporation makes up approx 1.52% of Van Cleef Asset Managementinc’s portfolio.

Stryker Corporation opened for trading at $111.38 and hit $111.91 on the upside on Tuesday, eventually ending the session at $111.75, with a gain of 0.39% or 0.43 points. The heightened volatility saw the trading volume jump to 16,69,941 shares. Company has a market cap of $41,792 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.